Ed has more than 20 years’ experience as an intellectual property attorney, both as in-house and outside counsel. He leverages this comprehensive legal perspective on behalf of his clients in the pharmaceutical industry and provides strategic, business-focused counsel in matters including product life-cycle management; IP due diligence for business transactions; patent, trademark, domain name, and copyright protection; global patent prosecution strategies; and freedom-to-operate analyses for pipeline products and in-licensing opportunities.

Before joining Mintz Levin, Ed was global IP counsel at Indivior PLC, formerly Reckitt Benckiser Pharmaceuticals. Prior to this, he was senior director of intellectual property at Amylin Pharmaceuticals, where he led the company’s IP group, and provided strategic legal and business advice to C-level management, business development, R&D, commercial operations, investor relations, and cross-functional teams on all areas of IP, including global IP strategies, collaboration and licensing agreements, and product life-cycle management. He started his legal career as outside counsel and he also has been a partner in the intellectual property practices of two other international law firms.